Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Non-Coding RNAs in Liver Disease, Injury, and Regeneration. | Cells | 2023 | 36766701 | PubTator, text mining | PubMed |
| Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin-Therapy: A 6-Year Retrospective Study. | Diagnostics (Basel) | 2023 | 36766607 | PubTator, text mining | PubMed |
Synthesis and Significance of Arachidonic Acid, a Substrate for Cyclooxygenases, Lipoxygenases, and Cytochrome P450 Pathways in the Tumorigenesis of Glioblastoma Multiforme, Including a Pan-Cancer Comparative Analysis. | Cancers (Basel) | 2023 | 36765904 | PubTator, text mining | PubMed |
| Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA. | Cancers (Basel) | 2023 | 36765775 | PubTator, text mining | PubMed |
| Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis. | Front Endocrinol (Lausanne) | 2023 | 36761200 | PubTator, text mining | PubMed |
| PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis. | Gastroenterology | 2023 | 36758837 | PubTator, text mining | PubMed |
| The role of hepatokines in NAFLD. | Cell Metab | 2023 | 36754018 | PubTator, text mining | PubMed |
| Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis. | Heliyon | 2023 | 36747946 | PubTator, text mining | PubMed |
| COVID-19-related liver injury: Focus on genetic and drug-induced perspectives. | World J Virol | 2023 | 36743658 | PubTator, text mining | PubMed |
| Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations. | Cell Mol Gastroenterol Hepatol | 2023 | 36740045 | PubTator, text mining | PubMed |
| Engineered Platforms for Maturing Pluripotent Stem Cell-Derived Liver Cells for Disease Modeling. | Cell Mol Gastroenterol Hepatol | 2023 | 36738860 | PubTator, text mining | PubMed |
| Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity. | Front Endocrinol (Lausanne) | 2023 | 36733529 | PubTator, text mining | PubMed |
| AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. | Hepatology | 2023 | 36727674 | PubTator, text mining | PubMed |
| MAFLD: a multisystem disease. | Ther Adv Endocrinol Metab | 2023 | 36726391 | PubTator, text mining | PubMed |
| PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review. | Liver Int | 2023 | 36719059 | PubTator, text mining | PubMed |
| Factors Associated with Liver Fibrosis in Chinese Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. | Int J Gen Med | 2023 | 36718143 | PubTator, text mining | PubMed |
| In silico profiling of nonsynonymous SNPs of fat mass and obesity-associated gene: possible impacts on the treatment of non-alcoholic fatty liver disease. | Lipids Health Dis | 2023 | 36717943 | PubTator, text mining | PubMed |
| Screening for MAFLD: who, when and how? | Ther Adv Endocrinol Metab | 2023 | 36699945 | PubTator, text mining | PubMed |
| Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection. | Sci Rep | 2023 | 36697471 | PubTator, text mining | PubMed |
| Inflammatory processes involved in NASH-related hepatocellular carcinoma. | Biosci Rep | 2023 | 36691794 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=46